Link between isolated para-aortic lymph node metastasis and intrauterine cancer site in early stage endometrial cancer

被引:0
|
作者
Cosma, Stefano [1 ]
Ferraioli, Domenico [2 ]
Borella, Fulvio [1 ]
Caretto, Marta [3 ]
Fuso, Luca [4 ]
Stura, Ilaria [5 ]
Bognanni, Francesca [1 ]
Borghi, Barbara [1 ]
Pace, Luca [4 ]
Preti, Mario [1 ]
Simoncini, Tommaso [3 ]
Chopin, Nicolas [2 ]
Benedetto, Chiara [1 ]
机构
[1] Univ Turin, S Anna Hosp, Dept Surg Sci, Gynecol & Obstet 1, Turin, Italy
[2] Leon Berard Comprehens Canc Ctr, Dept Gynecol, Leon, France
[3] Univ Pisa, Div Obstet & Gynecol, Dept Clin & Expt Med, Pisa, Italy
[4] Univ Turin, Umberto Hosp, Dept Surg Sci, Gynecol & Obstet Unit, Turin, Italy
[5] Univ Turin, Dept Publ Hlth & Pediat Sci, Turin, Italy
关键词
Sentinel Lymph Node; Uterine Cancer; Endometrial Neoplasms; Surgical Oncology; MULTICENTER; INJECTION; BIOPSY;
D O I
10.1136/ijgc-2024-005769
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Objective Missing occult para-aortic lymph node metastasis is one of the primary concerns of sentinel lymph node biopsy in endometrial cancer. Our study aimed to evaluate the relationship between intrauterine cancer site and isolated para-aortic lymph node metastasis to tailor treatment and reduce the false negative rate of the sentinel lymph node procedure. Methods A retrospective, multicenter, case control study was performed in four international centers. All patients with positive lymph nodes who had complete surgical staging with pelvic and para-aortic lymphadenectomy, between January 2013 and December 2023, were included. Detailed descriptions of the cancer location within the uterine cavity on the cranio-caudal plane and the myometrial wall involvement on the cranio-caudal and ventro-dorsal planes were collected, as were clinical data and cancer histological features. Patients with isolated para-aortic lymph node metastasis were allocated to group 1; patients with pelvic lymph node metastasis and those with both pelvic and para-aortic lymph node metastasis were allocated to group 2. The groups were compared according to the variables collected. Results 200 preoperative early stage endometrial cancer patients with postoperative International Federation of Gynecology and Obstetrics 2009/2023 stage IIIC1/IIIC2 were included in our study: 42 patients (21%) with isolated para-aortic lymph node metastasis were allocated to group 1 and the remaining patients to group 2. The two groups had comparable clinical and pathological characteristics (p>0.05): mean age was 66.510.3 (group 1) and 63.5 +/- 11.9 (group 2); endometrioid histotype was the predominant one for both groups (50%); most patients had myometrial infiltration >50% (80.9% and 79.7%), grade 3 (61.9% and 63.9%), and lymph vascular space invasion (78.5% and 82.2%). Cancers involving the fundal uterine cavity, the fundal myometrial wall, or the anterior myometrial wall were 3.11 (1.04-9.27), 3.03 (1.12-8.21), and 2.12 (0.77-5.80) times more likely to metastasize only to para-aortic lymph nodes compared with cancers located in other uterine sites. Conclusions In this study, the intrauterine location of the cancer determined the site of lymph node metastasis. When the tumor involved the fundus (cavity or wall) and infiltrated exclusively the anterior wall, the baseline risk of spreading only into the para-aortic area increased significantly in selected patients at risk of nodal disease.
引用
收藏
页码:1881 / 1887
页数:7
相关论文
共 50 条
  • [1] Incidence of isolated para-aortic lymph node metastasis in early stage endometrial cancer
    Nasioudis, Dimitrios
    Holcomb, Kevin
    EUROPEAN JOURNAL OF OBSTETRICS & GYNECOLOGY AND REPRODUCTIVE BIOLOGY, 2019, 242 : 43 - 46
  • [2] Is it possible to predict para-aortic lymph node metastasis in endometrial cancer?
    Turan, Taner
    Hizli, Deniz
    Sarici, Saynur
    Boran, Nurettin
    Gundogdu, Burcu
    Karadag, Burak
    Tulunay, Gokhan
    Kose, M. Faruk
    EUROPEAN JOURNAL OF OBSTETRICS & GYNECOLOGY AND REPRODUCTIVE BIOLOGY, 2011, 158 (02) : 274 - 279
  • [3] RISK FACTORS FOR PARA-AORTIC LYMPH NODE METASTASIS IN ENDOMETRIAL CANCER
    Sari, M. E.
    Yalcin, I.
    Sahin, H.
    Meydanli, M. M.
    Gungor, T.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2017, 27 : 224 - 225
  • [4] RISK FACTORS FOR PARA-AORTIC LYMPH NODE METASTASIS IN ENDOMETRIAL CANCER
    Sari, M. E.
    Yalcin, I.
    Sahin, H.
    Meydanli, M. M.
    Gungor, T.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2017, 27 : 96 - 97
  • [5] Outcomes of para-aortic lymphadenectomy in colorectat cancer with isolated para-aortic lymph node metastasis
    Choi, PH
    Kim, HC
    Yoon, YS
    Jung, SH
    Kim, AY
    Yu, CS
    Kim, JC
    DISEASES OF THE COLON & RECTUM, 2006, 49 (05) : 782 - 783
  • [6] Isolated para-aortic lymph node metastasis in completely staged endometrioid type endometrial cancer
    Ozdal, B.
    Oz, M.
    Yalcin, H.
    Sirvan, L.
    Gungor, T.
    Meydanli, M. M.
    EUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY, 2018, 39 (02) : 205 - 209
  • [7] Clinicopathological study on para-aortic lymph node metastasis without pelvic lymph node metastasis in endometrial cancer
    Tomisato, Shoko
    Yamagami, Wataru
    Susumu, Nobuyuki
    Kuwahata, Michiko
    Takigawa, Aya
    Nomura, Hiroyuki
    Kataoka, Fumio
    Hirasawa, Akira
    Banno, Kouji
    Aoki, Daisuke
    JOURNAL OF OBSTETRICS AND GYNAECOLOGY RESEARCH, 2014, 40 (06) : 1733 - 1739
  • [8] IMPLICATIONS OF PARA-AORTIC LYMPH NODE METASTASIS IN PATIENTS WITH ENDOMETRIAL CANCER WITHOUT PELVIC LYMPH NODE METASTASIS
    Todo, Y.
    Yamazaki, H.
    Shimada, C.
    Takeshita, S.
    Kato, H.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2017, 27 : 1231 - 1231
  • [9] Effectiveness of postoperative chemotherapy for para-aortic lymph node metastasis of endometrial cancer
    Takeshima, Nobuhiro
    Umayahara, Kenji
    Fujiwara, Kiyoshi
    Hirai, Yasuo
    Takizawa, Ken
    Hasumi, Katsuhiko
    GYNECOLOGIC ONCOLOGY, 2006, 102 (02) : 214 - 217
  • [10] IMPLICATIONS OF PARA-AORTIC LYMPH NODE METASTASIS IN PATIENTS WITH ENDOMETRIAL CANCER WITHOUT PELVIC LYMPH NODE METASTASIS
    Todo, Y.
    Yamazaki, H.
    Shimada, C.
    Takeshita, S.
    Kato, H.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2017, 27 : 472 - 472